Good summary. Just for clarity and accuracy......
Post# of 145414
![](/assets/46931549/no_avatar_available_thumb.jpg)
What was new and interesting (to me), was that NP said that in a Phase 2 trial, the secondary endpoints are just as important as the primary. I liked the fact that we seemed to have very strong results on the NEWS 2 secondary endpoint at each measurement period.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)